Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
about
Oligodendrogenesis in the normal and pathological central nervous systemThe innate immune system in demyelinating diseaseInhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelinationMacrophages promote axon regeneration with concurrent neurotoxicityTWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationCellular and Molecular Mechanisms Underpinning Macrophage Activation during RemyelinationRegenerative Capacity of Macrophages for RemyelinationCNS Remyelination and the Innate Immune SystemMyelin damage and repair in pathologic CNS: challenges and prospectsThe Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in reviewRemyelination therapy for multiple sclerosisPromoting remyelination in multiple sclerosis-recent advancesInfiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in miceNogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasmDelayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nervesMyelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signallingOligodendrocytes: biology and pathologyDealing with Danger in the CNS: The Response of the Immune System to Injury.Inefficient clearance of myelin debris by microglia impairs remyelinating processesProgressive multiple sclerosis: from pathogenic mechanisms to treatment.Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microgliaImportance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.Administration of a Sigma Receptor Agonist Delays MCAO-Induced Neurodegeneration and White Matter InjuryGlatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelinationGlatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patientsRemyelination can be extensive in multiple sclerosis despite a long disease course.Oligodendrocyte fate after spinal cord injury.Immune regulatory mechanisms influence early pathology in spinal cord injury and in spontaneous autoimmune encephalomyelitis.Metabolic reprograming of mononuclear phagocytes in progressive multiple sclerosis.Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cellsNeural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: a serial MR imaging study.Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin RepairAdoptive transfer of Th1-conditioned lymphocytes promotes axonal remodeling and functional recovery after spinal cord injury.Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies.Regeneration of myelin sheaths of normal length and thickness in the zebrafish CNS correlates with growth of axons in caliber.
P2860
Q21129352-A5B6434E-A6E8-4B74-83E5-9A7F50548DD5Q24597958-F3D2215E-8D7A-46EC-A390-AD1810F6FCA8Q24627168-1462A164-CE56-4F62-B567-549C1A76E956Q24648617-B0A037DF-B217-4D03-AA05-B9DCB6B1042EQ24670970-513A3815-90DF-41F4-9254-61F3CB1B1910Q26742081-0A87CA68-119C-4CE0-94D2-E7CB1F517AE3Q26744475-D02022D5-8EB5-49E8-BD5A-612B9EE17830Q26747242-46FB839C-7635-405D-A728-D89C87CC8B2CQ26797407-C96030C6-D4ED-4C7E-8283-98B05EF25449Q26801637-8939F913-C208-4766-B215-EEBB0635B0CBQ26824246-9740F657-2F3E-44C2-ADCE-93F4C2435046Q27010398-9D8A0E9A-FDEB-4991-92DA-9B4B15DE3A41Q27307172-3BCE0B7D-7E69-4C47-A9FF-2027BCA25C97Q27313149-79DAE573-7912-4130-BA70-1B79D37F962AQ27335500-69DA01D5-B3FF-4A1A-8290-A965E2082B5FQ28308310-4F7C9FCB-B845-4FD2-AF53-9190B97754E2Q30051584-9A5065F3-F343-4F08-AF75-1F888E86706BQ30279070-66AD258B-DDFF-4065-8537-C68E4D4344CEQ30636334-A72392AC-3EB0-47B8-AEF8-D9A9D4EF19ADQ31139925-D888566B-84B2-435B-8BF9-CBAABCDB1561Q33578973-520B49EB-93BB-4090-8A20-E661EE42B902Q33740931-F7B2FBEA-219F-4921-A053-EEAFBB18EB70Q33882403-E8C19033-0BF6-4433-9259-148633DA5068Q33913525-540A3780-9341-45AB-89BB-0B820E8690FAQ34143138-9F183C7C-B93E-41C6-A580-598A1ACAA371Q34253257-BEF13D60-AA09-4C3A-9AD7-245CC78ACFC0Q34532418-AB62858C-1DCC-4FF8-9552-001C033B99C3Q34578773-72B11ECD-436D-44CC-96BF-D8895BDFA55BQ35006477-3F55BC0D-83F8-4AB8-991B-1822F703C63FQ35083879-29C0EC8D-DEBC-41B7-8A01-E551976EEF03Q35167056-7F24965C-74E7-4DD3-89AE-645153451DC9Q35172658-E0EAB51F-3B9E-4038-8FF9-0F8188E0F63CQ35303782-13C6A637-6A0E-46C5-947B-9E49E346D4B6Q35461070-DD0E8255-5E6D-4265-AB7F-F8BC24F93DF6Q35589934-D21EF9FA-5D92-421E-AB9D-4356DED148D6Q35879420-C5F9F380-9A3D-49F5-B803-2F7F5F17293BQ35972372-E363DFD6-53B5-4991-9E3F-D21F0392F6F2Q36211471-BBDD38D9-4D74-45E8-A8E1-6F014923AD8CQ36212734-DB816774-3A71-42D5-967D-8177018B62CAQ36380800-BAC6F94D-2735-40C0-A5EB-7395C31F5869
P2860
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Macrophage depletion impairs o ...... ecithin-induced demyelination.
@en
Macrophage depletion impairs o ...... ecithin-induced demyelination.
@nl
type
label
Macrophage depletion impairs o ...... ecithin-induced demyelination.
@en
Macrophage depletion impairs o ...... ecithin-induced demyelination.
@nl
prefLabel
Macrophage depletion impairs o ...... ecithin-induced demyelination.
@en
Macrophage depletion impairs o ...... ecithin-induced demyelination.
@nl
P2093
P2860
P356
P1433
P1476
Macrophage depletion impairs o ...... ecithin-induced demyelination.
@en
P2093
Franklin RJ
Van Rooijen N
P2860
P304
P356
10.1002/GLIA.1085
P577
2001-09-01T00:00:00Z